Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke

American Journal of Hematology

Volumn 83, Issue 7, 2008, Pages 570-573

  Saidi, Sarra ^a   Mahjoub, Touhami ^a   Slamia, Lamia B ^b   Ammou, Sofyan B ^b   Al Subaie, Abeer M ^c   Almawi, Wassim Y ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; HUMAN PLATELET ANTIGEN 1; HUMAN PLATELET ANTIGEN 2; HUMAN PLATELET ANTIGEN 3; HUMAN PLATELET ANTIGEN 4; HUMAN PLATELET ANTIGEN 5; THROMBOCYTE ANTIGEN;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ALLELES; ANTIGENS, HUMAN PLATELET; BRAIN ISCHEMIA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STROKE;

EID: 45749147107     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21171     Document Type: Article

References (37)

1. Weyrich AS, Zimmerman GA. Platelets: Signalling cells in the immune continuum. Trends Immunol 2004;25:489-495.
2. Htun P, Fateh-Moghadam S, Tomandl B, et al. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke 2006;37:2283-2287.
3. Srivastava K, Dash D. Altered membrane fluidity and signal transduction in the platelets from patients of thrombotic stroke. Mol Cell Biochem 2001;224:143-149.
4. Santoso S. Clinical impact of platelet glycoprotein polymorphism. Vox Sang 2000;78:121-124.
5. Calvete JJ. Platelet integrin GPIIb/IIIa: Structure-function correlations. An update and lessons from other integrins. Proc Soc Exp Biol Med 1999;222:29-38.
6. Deckmyn H, Ulrichts H, Van De Walle G, et al. Platelet antigens and their function. Vox Sang 2004;87(Suppl 2):105-111.
7. Santoso S. Human platelet alloantigens. Transfus Apher Sci 2003;28:227-236.
8. Chen F, Jian Z, Xie Q, et al. Polymorphism of human platelet alloantigen in Chinese patients with acute myocardial infarction and acute ischemic stroke. Chin Med J 2000;113:702-705.
9. Bray PF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 2000;7:284-289.
10. Kunicki TJ. The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 2002;22:14-20.
11. Ulrichts H, Vanhoorelbeke K, Cauwenberghs S, et al. von Willebrand factor but not α-thrombin binding to platelet glycoprotein Ibα is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 2003;23:1302-1307.
12. Kuijpers RWAM, Faber NM, Cuypers HTM, et al. The N-terminal globular domain of the human platelet glycoprotein Iba has a methionine 145/threonine 145 amino acid polymorphism which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992;89:381-384.
13. 2 integrin) allele frequencies in three North American populations reveals genetic association between nucleotide 807C/T and amino acid 505 Glu/Lys (HPA-5) dimorphisms. Thromb Haemost 1998;80:449-456.
14. Halle L, Bigot A, Mulen-Imandy G, et al. HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. Tissue Antigens 2005;65:295-298.
15. Yan L, Zhu F, He J, et al. Human platelet alloantigen systems in three Chinese ethnic populations. Immunohematology 2006;22:6-10.
16. Seo DH, Park SS, Kim DW, et al. Gene frequencies of eight human platelet-specific antigens in Koreans. Transfus Med 1998;8:129-132.
17. Chang YW, Mytilineos J, Opelz G, et al. Distribution of human platelet antigens in a Chinese population. Tissue Antigens 1998;51(4, Part 1):391-393.
18. Jones DC, Bunce M, Fuggle SV, et al. Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles. Eur J Immunogenet 2003;30:415-419.
19. Ferrer G, Muniz-Diaz E, Aluja MP, et al. Analysis of human platelet antigen systems in a Moroccan Berber population. Transfus Med 2002;12:49-54.
20. Streifler JY, Rosenberg N, Chetrit A, et al. Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 2001;32:2753-2758.
21. Carter AM, Catto AJ, Bamford JM, et al. Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke 1999;30:2606-2611.
22. Baker RI, Eikelboom J, Lofthouse E, et al. Platelet glycoprotein Ibα Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001;98:36-40.
23. Carlsson LE, Greinacher A, Spitzer C, et al. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 1997;28:1392-1395.
24. Meiklejohn DJ, Vickers MA, Morrison ER, et al. In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 2001;112:621-631.
25. Kekomaki S, Hamalainen L, Kauppinen Makelin R, et al. Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 1999;6:13-17.
26. Wagner KR, Giles WH, Johnson CJ, et al. Platelet glycoprotein receptor IIIa polymorphism P1A2 and Ischemic stroke risk: The Stroke Prevention in Young Women Study. Stroke 1998;29:581-585.
27. Iniesta JA, Gonzalez-Conejero R, Piqueras C, et al. Platelet GP IIIa polymorphism HPA-1 (PIA) protects against subarachnoid hemorrhage. Stroke 2004;35:2282-2286.
28. Hato T, Minamoto Y, Fukuyama T, et al. Polymorphism of HPA-1 through 6 on the platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 1997;80:1222-1224.
29. Li YH, Chen JH, Tsai WC, et al. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost 2002;87:86-91.
30. Voetsch B, Damasceno BP, Camargo EC, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000;83:229-233.
31. Araujo F, Santos A, Araujo V, et al. Genetic risk factors in acute coronary disease. Haemostasis 1999;29:212-218.
32. Charakida M, Tousoulis D, Stefanadis C, et al. The impact of platelet glycoprotein IIIa and Ia polymorphisms in cardiovascular thrombotic disease. Ital Heart J 2003;4:17-22.
33. Carlsson LE, Santoso S, Spitzer C, et al. The α2 gene coding sequence T807/A873 of the platelet collagen receptor integrin α2β1 might be a genetic risk factor for the development of stroke in younger patients. Blood 1999;93:3583-3586.
34. Kluter H. Rapid typing for human platelet antigens systems -1, -2, -3 and -5 by PCR amplification sequence-specific primers. Vox Sang 1996;71:121-123.
35. Hurd CM, Cavanagh G, Schuh A, et al. Genotyping for platelet-specific antigens: Techniques for the detection of single nucleotide polymorphisms. Vox Sang 2002;83:1-12.
36. Metcalfe P, Cavanagh G, Hurd C, et al. HPA genotyping by PCR-SSP: Report of 4 exercises. Vox Sang 1999;77:40-43.
37. Cavanagh G, Dunn AN, Chapman CE, et al. HPA genotyping by PCR sequence-specific priming (PCR-SSP): A streamlined method for rapid routine investigations. Transfus Med 1997;7:41-45.